Phase 1 Study of XL119, a Rebeccamycin Analog, in Patients With Refractory Hematologic MalignanciesBORTHAKUR, Gautam; ALVARADO, Yesid; RAVANDI-KASHANI, Farhad et al.Cancer. 2008, Vol 113, Num 2, pp 360-366, issn 0008-543X, 7 p.Article

Phase I trial of rebeccamycin analog (NSC #655649) in children with refractory solid tumors: A pediatric oncology group studyLANGEVIN, Anne-Marie; WEITMAN, Steven D; KUHN, John G et al.Journal of pediatric hematology/oncology. 2003, Vol 25, Num 7, pp 526-533, issn 1077-4114, 8 p.Article

A phase II study of rebeccamycin analog NSC 655649 in patients with metastatic colorectal cancerGOEL, Sanjay; WADLER, Scott; HOFFMAN, Anthony et al.Investigational new drugs. 2003, Vol 21, Num 1, pp 103-107, issn 0167-6997, 5 p.Article